Astellas Pharma

Astellas and Pfizer study enfortumab vedotin with pembrolizumab in muscle-invasive bladder cancer

Astellas Pharma, in collaboration with Pfizer, is conducting Phase II trial (NCT07475806) to evaluate the efficacy of enfortumab vedotin combined with pembrolizumab in adults diagnosed with muscle-invasive bladder cancer.

Roxadustat Study for Anemia in Children with Chronic Kidney Disease Initiated by Astellas Pharma

Astellas Pharma is conducting a study to evaluate the efficacy of roxadustat in treating anemia in children and teenagers with chronic kidney disease, with a duration of up to 52 weeks.

Astellas Pharma initiates trial of ASP2138 for HER2-negative gastric cancer